L. Knoops

1.0k total citations · 1 hit paper
13 papers, 628 citations indexed

About

L. Knoops is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, L. Knoops has authored 13 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in L. Knoops's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). L. Knoops is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). L. Knoops collaborates with scholars based in Belgium, France and Austria. L. Knoops's co-authors include Jean‐Christophe Renauld, Tiziano Barbui, Mark M. Jones, Heinz Gisslinger, Viktoriya Stalbovskaya, Alessandro M. Vannucchi, Haifa Kathrin Al‐Ali, Mari McQuitty, Claire Harrison and P. Gopalakrishna and has published in prestigious journals such as Oncogene, Annals of Oncology and Leukemia.

In The Last Decade

L. Knoops

13 papers receiving 623 citations

Hit Papers

Long-term findings from COMFORT-II, a phase 3 study of ru... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Knoops Belgium 7 426 338 281 155 146 13 628
Elisabeth Oppliger Leibundgut Switzerland 16 311 0.7× 412 1.2× 480 1.7× 102 0.7× 178 1.2× 38 897
Marianne Rosamilia United States 5 309 0.7× 483 1.4× 163 0.6× 215 1.4× 119 0.8× 7 684
Abdulraheem Yacoub United States 15 551 1.3× 467 1.4× 366 1.3× 212 1.4× 206 1.4× 122 917
Emmanuelle Verger France 15 468 1.1× 432 1.3× 299 1.1× 202 1.3× 80 0.5× 34 663
Xavier Calvo Spain 12 388 0.9× 360 1.1× 219 0.8× 52 0.3× 104 0.7× 43 582
Marie Colombat France 2 249 0.6× 353 1.0× 85 0.3× 300 1.9× 55 0.4× 4 488
Abhijit Ramachandran United States 11 247 0.6× 565 1.7× 410 1.5× 22 0.1× 131 0.9× 28 926
Lurdes Zamora Spain 13 253 0.6× 328 1.0× 280 1.0× 45 0.3× 271 1.9× 55 824
Manuel Ayala Mexico 4 854 2.0× 1.0k 3.0× 103 0.4× 548 3.5× 172 1.2× 10 1.2k
Srinivas K. Tantravahi United States 11 168 0.4× 199 0.6× 245 0.9× 44 0.3× 173 1.2× 70 597

Countries citing papers authored by L. Knoops

Since Specialization
Citations

This map shows the geographic impact of L. Knoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Knoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Knoops more than expected).

Fields of papers citing papers by L. Knoops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Knoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Knoops. The network helps show where L. Knoops may publish in the future.

Co-authorship network of co-authors of L. Knoops

This figure shows the co-authorship network connecting the top 25 collaborators of L. Knoops. A scholar is included among the top collaborators of L. Knoops based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Knoops. L. Knoops is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Knoops, L., Gregor Verhoef, Z. N. Berneman, et al.. (2016). Real-world data from 54 Belgian patients from the ponatinib named patient programme (NPP). Ghent University Academic Bibliography (Ghent University). 1 indexed citations
2.
Harrison, Claire, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, et al.. (2016). Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia. 30(8). 1701–1707. 350 indexed citations breakdown →
3.
Béguin, Yves, Barbara Dessars, Timothy Devos, et al.. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Open Repository and Bibliography (University of Liège). 6(1). 16–32. 1 indexed citations
4.
Renauld, Jean‐Christophe, et al.. (2015). JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications. Haematologica. 100(10). 1240–1253. 42 indexed citations
5.
Devos, Timothy, Pierre Zachée, Dominique Bron, et al.. (2014). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica. 70(2). 105–111. 6 indexed citations
6.
Girardot, Michael, C. Pecquet, Ilyas Chachoua, et al.. (2014). Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation. Oncogene. 34(10). 1323–1332. 31 indexed citations
7.
Knoops, L., Christine Sempoux, Christine Galant, et al.. (2014). Solitary extramedullary plasmocytoma of the thyroid: a case report and histological approach to plasma cells infiltrate in the thyroid gland. Acta Clinica Belgica. 70(2). 133–137. 4 indexed citations
8.
Montano‐Almendras, Carmen P., Ahmed Essaghir, Hélène Schoemans, et al.. (2012). ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor- B. Haematologica. 97(7). 1064–1072. 37 indexed citations
9.
Schmitz, Sandra, Stéphanie Henry, L. Geoffrois, et al.. (2012). Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). Annals of Oncology. 23(8). 2153–2161. 62 indexed citations
10.
Hornakova, Tekla, et al.. (2011). Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors. Haematologica. 96(6). 845–853. 54 indexed citations
11.
Knoops, L., Cédric Hermans, Augustin Ferrant, & Stefan N. Constantinescu. (2008). CLINICAL IMPLICATIONS OF JAK2 MUTATIONS IN MYELOPROLIFERATIVE DISORDERS. Acta Clinica Belgica. 63(2). 93–98. 4 indexed citations
12.
Knoops, L., Tekla Hornakova, Yohan Royer, Stefan N. Constantinescu, & Jean‐Christophe Renauld. (2007). JAK kinases overexpression promotes in vitro cell transformation. Oncogene. 27(11). 1511–1519. 34 indexed citations
13.
Knoops, L., et al.. (2002). ANGIOIMMUNOBLASTIC LYMPHADENOPATHY FOLLOWING CIPROFLOXACIN ADMINISTRATION. Acta Clinica Belgica. 57(2). 71–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026